V
TWENTIETH CONGRESS OF THE 
)
REPUBLIC OF THE PHILIPPINES 
)
First Regular Session 
)
t r 
■[c
or ii\: 
.• {uirj:
25 AUG-5 P3 :41
S. No
SENATE
920
RrCiIVcO BV
Introduced by Senator Jinggoy Ejercito Estrada
AN ACT
CREATING THE PHILIPPINE CENTER FOR DISEASE PREVENTION AND 
CONTROL, DEFINING ITS POWERS AND FUNCTIONS, APPROPRIATING 
FUNDS THEREFOR, AND FOR OTHER PURPOSES
EXPLANATORY NOTE
Article II, Section 15 of the Philippine Constitution provides that, "The State 
shall protect and promote the right to health of the people and instill health 
consciousness among them."
Communicable and non-communicable diseases continue to pose serious threat 
to the health and lives of our people. The cure for these diseases and the continuous 
research on how to prevent them have been in the priority of the government but the 
synchronization and coordination of efforts of various government entities should be 
given an equally important attention.
In a study of the World Health Organization and the United Nations 
Development Programme in 2019 entitled, "Prevention and control of 
noncommunicable diseases in the Philippines: The case for investment", the following 
key findings were presented:


• 
Non-communicable diseases (NCDs) account for 68% of all deaths in the 
Philippines, and the probability of dying between the ages of 30 and 70 years 
from one of the four main NCDs is 29% in the Philippines.
• 
The economic cost of NCDs to the Philippine economy is PHP 756.5 billion per 
year, which is equivalent to 4.8% of the country's annual gross domestic 
product.
• 
NCDs in the Philippines are causing a surge in health-care costs and social care 
and welfare support needs and are contributing to reduced productivity.
• 
Actions to prevent NCDs in the Philippines are relatively cheap and cost- 
effective.
• The economic modelling for the return on investment analysis suggests that 
the intervention with highest economic benefit in Philippines is the package of 
salt-reduction interventions, followed by reducing tobacco consumption and 
increasing physical activity in the population.
• 
A national multisectoral NCD coordination mechanism needs to be established 
that can bring together and strengthen existing cross-agency initiatives on 
NCDs.
On May 2022, the United States Centers for Disease Control and Prevention 
(CDC) opened its new country office in the Philippines as part of its endeavors to 
advance increased health security in Asia. The Department of Health and the US 
Department of Health and Human Services signed a memorandum of understanding 
on increasing collaboration between the US and the Philippines on public health 
emergency and response, prevention and control of vaccine-preventable and 
communicable disease, and the prevention and control of non-communicable 
diseases.1 This development will be helpful in intensifying the country's efforts in this 
field. It does not discount, however, the need to improve the current health 
infrastructure of the country to achieve these goals.
1 us CDC opens new country office in Philippines I Philstar.com


According to CDC, the country needs to intensify its efforts to address infectious 
diseases which remains prevalent among its people. For one, the Philippines is 
experiencing the fastest growing HIV epidemic in the Western Pacific region, with a 
411% increase in daily HIV incidence between 2012 and 2023.2 In April 2024, UNICEF 
reported that the country is experiencing outbreaks in three highly infectious diseases 
for children namely, measles, pertussis, and polio.3 Meanwhile, the Department of 
Health, in an article published on April 3, 2025, warned that dengue outbreak is 
possible this year. From January 1 to March 15 alone, there is a total of 76,425 dengue 
cases that were recorded, a 78% increase from the 42,822 cases recorded during the 
same period last year.4
These data prove that there is much to be done to improve the health services 
that the government provides to the people.
The "Philippine Center for Disease Control and Prevention (CDC) seeks to 
protect the people from the impact of communicable and non-communicable diseases 
of public health importance by adopting an integrated, comprehensive, and evidence- 
based approach within a framework that fosters a whole-of-system, whole-of- 
government and whole-of-society approach, ensuring clear delineation of tasks 
between existing agencies and maximizes current mandates. It establishes the 
Philippine Center for Disease Control and Prevention (CDC) which shall be under the 
Office of the Secretary of the DOH and will be headed by a Director General.
Under the proposed measure, several existing offices and units will be 
restructured to ensure clear delineation of functions and effective coordination. This 
includes the Research Institute for Tropical Medicine (RITM) which will be transferred 
from the Office of the Secretary of Health to the CDC.
2 CDC in Tanzania
3 Measles and pertussis outbreaks a wake-up call for the Philippines
4 Dengue outbreak possible this year, warns DOH I ABS-CBN News


Also provided under the bill is the establishment of Philippine Health Laboratory 
System which will unify all diagnostic surveillance of public health importance into 
stand-alone laboratories across the nation. It will transition the identified public health 
laboratories that are currently housed in their existing host hospitals into stand-alone 
laboratory facilities to serve as a diagnostic surveillance centers separate from its 
hospital operations.
In view of the foregoing, the immediate passage of this measure is highly 
recommended.
NGGOY EJERCITO ESTRADA


TWENTIETH CONGRESS OF THE 
)
REPUBLIC OF THE PHILIPPINES 
)
First Regular Session 
)
SENATE
s. No. 920
''■‘■■BUltf n[ t! -' ■ '■t.Ti'P
25 AUG-5 P3 ’•41
RliCEIVED 3'
Introduced by Senator Jinggoy Ejercito Estrada
AN ACT
CREATING THE PHILIPPINE CENTER FOR DISEASE PREVENTION AND 
CONTROL, DEFINING ITS POWERS AND FUNCTIONS, APPROPRIATING 
FUNDS THEREFOR, AND FOR OTHER PURPOSES
Be it enacted by the Senate and the House of Representatives of the Philippines in 
Congress assembled:
1 
ARTICLE I
2 
TITLE AND GUIDING PRINCIPLES
3 
Section 1. Short Title. — This Act shall be known as the '"'Philippine Center for
4 
Disease Prevention and Control (CDC) Acf.
5 
Sec. 2. Declaration of Policy. — It is the policy of the State to protect and
6 
promote the right to health of all Filipinos and instill health consciousness among them.
7 
To this end, the State shall adopt an integrated, comprehensive, and evidence-
8 
informed approach consistent with the direction under Republic Act No. 11223 or the
9 
Universal Health Care Act, and adopt a framework that shall foster a whole-of-system,
10 
whole-of-government, and whole-of-society approach, ensuring clear delineation of
11 
tasks among existing agencies and maximizing current mandates. The State shall also
12 
allot the necessary support and institutional resources to provide for effective disease
13 
prevention and control through a high-level public institution imbued with the capacity,
14 
competence, and authority to confront global and local public health risks.
15 
Sec. 3. Objectives. — The objectives of this Act are the following:


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
(a) Protect the Filipino people from the impact of all diseases of public health 
importance;
(b) Develop policies, plans, and protocols to improve identified areas in the 
International Health Regulations hazards;
(c) Clarify governance, decision-making, communication, and coordination 
processes and protocols related to identifying, diagnosing, forecasting, 
preventing, controlling, eliminating, eradicating, and monitoring all 
diseases of public health importance;
(d) Formulate and implement policies, plans, programs and projects for the 
promotion of scientific and technological activities for both the public 
and private sectors, and ensure that the results of scientific and 
technological activities are properly applied and utilized to uphold 
technical and scientific integrity in decision-making and response;
(e) Ensure swift, coordinated, and data-driven surveillance and response 
through the Department of Health (DOH), epidemiology and surveillance 
units, public health laboratory systems, points of entry, and the Disaster 
Risk Reduction and Management System;
(f) Provide the overall national framework and strategic direction for the 
establishment of a health laboratory system;
(g) Maintain a pool of in-house experts who shall serve as the technical 
authority and shall provide evidence-informed guidance on standards, 
technologies, and analytics for epidemiology, disease control, 
prevention, elimination, eradication, health emergency preparedness, 
and response; and
(h) Ensure the development and implementation of a shared risk and crisis 
communication plan with the DOH, the Food and Drug Administration 
(FDA), and Research Institute for Tropical Medicine (RUM), to be known 
under this Act as the Philippine Research Institute of Medicine.
ARTICLE II
DEFINITION OF TERMS
Sec. 4. Definition of Terms. — As used in this Act:


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
(a) Commodities for pubiic heaith emergencies refer to health products 
necessary for public health emergency response. These may include 
vaccines, therapeutics, medical devices, and ancillary supplies;
(b) Disease refers to pathologic acute or rapidly developing and chronic or 
long-standing conditions that cause harmful deviations from normal 
structure or function and may be due to infectious agents or their toxic 
products, which may be transmitted from a reservoir to a susceptible 
host (either directly from an infected person or animal or indirectly 
through the agency of an intermediate plant or animal host, vector, or 
the inanimate environment, or coming from laboratories intentionally or 
unintentionally) or may be the result of a combination of genetic, 
physiological, environmental, and behavioral factors. This shall refer to 
all diseases, including communicable and non-communicable diseases;
(c) Disease surveiiiance refers to the ongoing systematic collection, analysis, 
interpretation, and dissemination of outcome-specific data for use in the 
planning, implementation, and evaluation of public health practice in 
terms of epidemics, emergencies, and disasters. A disease surveillance 
system includes the functional capacity for data analysis as well as the 
timely dissemination of these data to persons who can undertake 
effective prevention and control activities;
(d) Heaith Research refers to research or research-related activities that 
seek to provide timely and quality evidence to address knowledge gaps 
in areas related to identifying, diagnosing, forecasting, preventing, 
controlling, eliminating and eradicating, and monitoring diseases of 
public health importance;
(e) Internationai Heaith Reguiations refers to an international agreement 
managed by the World Health Organization (WHO) and is focused on 
addressing serious public health threats that have the potential to spread 
beyond a country's borders to other parts of the world, and defines the 
standards that countries must meet to be able to prevent, detect, and 
respond to public health threats;


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
(f) Notifiable disease refers to a disease that, by legal requirements, must 
be reported to the public health authorities;
(g) Public health emergency refers to an occurrence or imminent threat of 
an illness or health condition that:
(1) Is caused by any of the following:
(i) 
Bioterrorism;
(ii) 
Appearance of a novel or previously controlled or 
eradicated infectious agent or biological toxin;
(iii) 
Natural disaster;
(iv) 
Chemical attack or accidental release;
(v) 
Nuclear attack or accident; or
(vi) 
Attack that uses or is caused by an accidental release of 
radioactive materials; and
(2) Poses a high probability of any of the following:
(i) Large number of deaths in the affected population;
(ii) Large number of serious injuries or long-term disabilities 
in the affected population;
(iii) Widespread exposure to an infectious or toxic agent that 
poses a significant risk of substantial harm to a large 
number of people in the affected population;
(iv) International exposure to an infectious or toxic agent that 
poses a significant risk to the health of citizens of other 
countries; or
(v) Trade and travel restrictions.
(h) Public health refers to either a public health emergency or a public 
health threat due to biological, chemical, radio-nuclear, or environmental 
agents;
(i) Public health laboratories refer to facilities responsible for providing 
timely and reliable diagnostic results primarily for improvement of 
patient outcomes, disease prevention, control, and surveillance, 
population-based interventions, and outbreak emergency response.


1 
They shall perform core public health and environmental activities,
2 
including reference tests for diseases of public health importance;
3 
(j) Public health threat refers to any situation or factor that may present a
4 
danger to the health of the people;
5 
(k) Quarantine refers to the restriction of activities and/or separation from
6 
others of suspect persons who are not ill, or of suspect baggage,
7 
containers, conveyances, or goods, in such a manner as to prevent the
8 
possible spread of infection or contamination;
9 
(I) Response refers to the implementation of specific activities to control
10 
further spread of infection, outbreaks, or epidemics and prevent
11 
reoccurrence. It includes verification, contact tracing, rapid risk
12 
assessment, case measures, treatment of patients, risk communication,
13 
the conduct of prevention activities, and rehabilitation.
14 
ARTICLE III
15 
CREATION AND FUNCTIONS OF THE PHILIPPINE CENTER FOR DISEASE
16 
PREVENTION AND CONTROL
17 
Sec. 5. Creation of the Philippine Center for Disease Prevention and Control.
18 
— There is hereby established an agency to be known as the Philippine Center for
19 
Disease Prevention and Control, hereinafter referred to as "CDC". The CDC shall be
20 
an agency directly under the DOH's Office of the Secretary.
21 
Sec. 6. Functions of the CDC. — The CDC shall be a science-based organization
22 
that shall be the technical authority on forecasting, analysis, strategy, and standards
23 
development for the prevention and control of all diseases of public health importance
24 
and health security events, whether domestic or international in origin. The CDC shall
25 
coordinate with centers for disease control of other countries and act as the National
26 
Focal Point of the Philippines for International Health Regulations concerns.
27 
For purposes of this Act, the "National Focal Point" shall refer to a national
28 
office or center that is accessible at all times for International Health Regulations
29 
related communications with the WHO and relevant sectors within the country.
30 
The functions of the CDC shall include, but not limited to, the following:
31 
(a) Develop strategies, standards, and policies for disease prevention and
32 
control;


1 
(b) implement disease surveillance and field epidemiology activities;
2 
(c) Perform data collection and analytics;
3 
(d) Establish and strengthen public health laboratories;
4 
(e) Recommend actions for public health threats to appropriate national
5 
government bodies;
6 
(f) Lead public health and risk communications;
7 
(g) Conduct and manage health research and evidence synthesis;
8 
(h) Build local capacity for surveillance and health research; and
9 
(i) Promote scientific integrity by ensuring that all its products are technically
10 
accurate, scientifically and ethically sound, and useful to the government
11 
and the intended population through the institutionalization of appropriate
12 
mechanisms and bodies
13 
The CDC shall perform other functions as may be mandated by law or duly
14 
delegated by relevant authorities, as well as those that may be necessary or expedient
15 
for the performance of its mandate under this Act.
16 
The CDC shall submit annual detailed cost work plans relating to its functions
17 
to the Secretary of Health for approval.
18 
Sec. 7. Structure of the CDC. —
19 
(a) The CDC shall be headed by a Director General.
20 
(b)The CDC shall have established component centers that shall lead and
21 
coordinate the major functions of the CDC and establish strategic linkages
22 
and partnerships to fulfill its mandate. In line with the CDCs functions, each
23 
of the following component centers shall be headed by a Deputy Director
24 
General:
25 
(1) Center for Health Statistics. The Center for Health Statistics shall provide
26 
the national leadership in health statistics, data analytics, and health
27 
information systems management of non-epidemiologic surveys in
28 
coordination with the Philippine Statistics Authority and shall
29 
complement the roles and responsibilities of the DOH related to sectoral
30 
policy and planning by providing relevant health statistics. It shall
31 
likewise progressively develop and expand its methodological and
32 
analytical capacity; its use of informatics, digital tools, innovations.


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
among others; and expand its portfolio of national health-related surveys 
that it develops and manages to complement existing national health 
surveys being managed by other national agencies.
(2) Center for Epidemiology and Surveillance. The Center for Epidemiology 
and Surveillance shall lead and execute a national public health 
surveillance strategy and shall perform the functions and obligations of 
the Epidemiology Bureau and the DOH under Sections 5, 6, and 8 of 
Republic Act No. 11332, or the Mandatory Reporting of Notifiable 
Diseases and Health Events of Public Health Concern Act. Further, it 
shall progressively enhance its epidemiology and surveillance functions 
to further develop its overall analytical capacity; to expand the scope of 
surveilled events and diseases; to set standards for and continually 
expand tools for data management and surveillance systems; to expand 
the scope of data collected; to lead in the development of epidemiology 
and surveillance capacities for all diseases and their causes, including 
social determinants of health; to lead in implementing international 
health surveillance and International Health Regulations processes; and 
to expand its technical expertise to include other and emerging branches 
and types of epidemiology and relevant epidemiologically related 
approaches.
(c) Research Institute for Tropical Medicine (RITM) - The RITM, which shall 
henceforth be referred to as the Philippine Research Institute of Medicine, 
shall be directly under the CDC and continue to perform its current functions 
through its Clinical Research Division, Laboratory Research Division, and 
Biologies Manufacturing Division. To complement the CDCs functions, the 
Philippine Research Institute of Medicine shall perform the following 
additional functions:
(l)lead evidence-informed policy-making for the prevention and control of 
all diseases, which as defined in Section 4 of this Act includes 
communicable and non-communicable diseases, through the synthesis 
of available evidence;


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
(2) conduct high-quality health research and develop evidence informed 
strategies and standards of care, and provide scientific inputs to guide 
the development, evaluation, and improvement of public health 
programs;
(3) develop science-informed standards to address public health threats, in 
partnership with academe, professional societies, research bodies. 
National Institutes of Health, and the Department of Science and 
Technology (DOST);
(4) develop and provide the overall strategic direction, policies, standards, 
and plans in the implementation of the Philippine Health Laboratory 
System (formerly the RITM's laboratories, DOH's Health Laboratories, 
and other identified national laboratories) and the institutionalization of 
stand-alone CDC public health laboratories, including national reference 
laboratories, subnational, and regional public health laboratories, which 
shall be expanded through the establishment of streamlined diagnostic 
tests and surveillance of diseases of public health importance into stand­
alone laboratories across the nation and by ensuring an effective and 
efficient quality management system for all clinical and other health 
laboratories in partnership with the DOH: Provided, That the Philippine 
Research Institute of Medicine shall lead the country's public health 
laboratory response for rapid detection of emerging and reemerging 
public health threats;
(5) promote and develop innovative science, technologies, and processes in 
support of CDC's ability to protect the country from health, safety, and 
security threats, both foreign and local;
(6) manufacture vaccines and biologicals, consistent with the self-reliance 
action plan, subject to a positive recommendation issued by an 
independent study or body commissioned by relevant national 
government agencies;
(7) develop and implement, together with other agencies, such as DOST 
and the Department of Trade and Industry (DTI), programs for vaccine


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
32
and biologies capacity building on human resources, infrastructures, and 
technology, among others;
(8) coordinate, oversee, and lead the development of the vaccine self 
reliance national action plan, including sustainability models and plans 
on local vaccine development and involvement of the manufacturing 
industry;
(9) promote and advocate technology transfers and cross-border exchanges 
of scientific information, data, and physical samples both at the vaccine 
and biologies research and development, and other steps in the 
manufacturing and trade value chain;
(10) 
establish linkages with local and international public and private 
partners and industries in vaccine and biologies development and 
manufacturing initiatives and coilaborations; and
(11) 
perform such other necessary functions mandated under this Act, 
or as may be mandated by law, or as may be delegated by the Secretary 
of Health and/or the President.
Provided, That nothing in this Act shall prohibit the CDC from 
establishing additional divisions, bureaus, and offices under the 
Philippine Research Institute of Medicine.
(d) The CDC shall have three (3) offices directly under the Director General to 
support the Center for Health Statistics, Center for Epidemiology and 
Surveillance, and the Philippine Research Institute of Medicine, namely:
(1) Office for Health Economics;
(2) Office for Policy and Planning; and
(3) Office for Administration, Finance, and Legal Affairs.
(e) Technical committees, boards, commissions, councils, conferences, task 
forces, or similar groups shall be established to provide technical expert 
advice, ideas, and diverse opinions to the CDC. Advisory committees shall 
be composed of experts from different sectors with specific expertise 
necessary to fulfill their mandate: Provided, That membership to the 
advisory committee shall be renewed every three (3) years, but may be 
terminated earlier as deemed necessary.


1 
(f) Regional Centers of the CDC shall be established to strengthen local
2 
technical capacity for epidemiology and surveillance, health statistics,
3 
laboratory, and research that would support DOH regional offices and iocai
4 
government units (LCDs).
5 
(g) Additionai offices may be created in accordance with the mandate of the
6 
CDC with the recommendation of the Director General and approval of the
7 
Secretary of Health in view of emerging needs of the health sector.
8 
ARTICLE IV
9 
OPERATIONAL STRUCTURE, MANAGEMENT, AND STAFF OF THE CENTER
10 
Sec. 8. Relationship with Existing Agencies and Oifices. -
11 
(a) Relationship between CDC and DOH Operations. The CDC shali be an
12 
agency under the DOH's Office of the Secretary. The DOH shail develop
13 
operational and intersectoral policies to support implementation of
14 
strategies and standards developed by the CDC.
15 
(b) Relationship between CDC and the DOH Bureau of Quarantine. The CDC
16 
shali set the standards for international health surveillance and surveillance
17 
at ports of entry and coordinate with the Bureau of Quarantine for
18 
operationaiization and stakeholder management.
19 
(c) Relationship between CDC and University of the Philippines-National
20 
Institute of Health (UP-NIH). The UP-NIH shall provide support to the CDC
21 
in developing and impiementing its research agenda and in implementing
22 
programs to ensure the continuation of professional, academic, and
23 
personai capacity development of multisectoral stakeholders that will be
24 
engaged with the CDC.
25 
(d) Relationship between Regional Office of the CDC and DOH Regional Offices.
26 
The CDC shall have regional counterparts that will maintain technical
27 
capacity for epidemiology and surveillance, health statistics, laboratory, and
28 
research, as support to DOH regional offices and LGUs to support
29 
implementation of strategies and standards of the CDC.
30 
(e) Relationship between CDC and LGUs. Provinces, cities, and municipalities
31 
shali adopt and iocalize standards and guidelines developed by the CDC, as
32 
operationalized by the DOH, in the performance of activities related to
10


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
32
disease prevention and control. Further, LGUs shall allocate the necessary 
funding for the establishment of functional Epidemiology and Surveillance 
Units based on standards set by the Center for Epidemiology and 
Surveillance and as provided for by law, including the creation of positions 
for needed Disease Surveillance Officers and field epidemiologists in line 
with the goal of building local capacity for health surveillance: Provided, 
That the CDC will provide technical support to LGUs.
Sec. 9. Transfer of Agencies. —
(a) Restructuring of Affected Offices and Units. The following offices, including 
their administrative units, shall be restructured to ensure synergistic co­
existence of the CDC and DOH to facilitate full operations of the CDC.
(1) The Health Laboratory Division of the Health Facility Development 
Bureau of the DOH, also referred to as the Office for Health Laboratories, 
and other identified national reference laboratories shall be absorbed by 
the Philippine Research Institute of Medicine and included in the 
Philippine Health Laboratory System
(2) The Epidemiology Bureau of the DOH shall be transferred to the Center 
for Health Statistics and Center for Epidemiology and Surveillance in 
phases. The functions of the National Epidemiology Center of the 
Epidemiology Bureau and disease and public health surveillance 
functions assigned to the DOH by law shall also be transferred to the 
Center for Epidemiology and Surveillance. In line with this, the Regional 
Epidemiology and Surveillance Units and Field Health Services 
Information System Units of the DOH Regional Offices shall be 
transferred to and be under the sole supervision and control of the CDC 
upon the effective transition of the Epidemiology Bureau to the CDC.
The Center for Epidemiology and Surveillance shall set the 
standards for international health surveillance and surveillance at ports 
of entry and shall coordinate with the Bureau of Quarantine for 
operationalization and stakeholder management: Provided, That the 
screening and quarantine processes for inbound and outbound 
international travelers as provided under Sections 4 and 5 of Republic
11


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
32
Act No. 9271, or the Quarantine Act of2004 shall remain with the Bureau 
of Quarantine, aligned with the standards promulgated by the CDC.
(3) The Knowledge Management and Information Technology Service 
(KNITS) of the DOH shall be restructured and rationalize its functions to 
eliminate the overlaps and duplication with the standards and sectorai 
policy function of the Center for Health Statistics.
(4) The Disease Prevention and Control Bureau shall be transformed into 
the Public Health Strategy and Management Bureau, and shall be 
responsible for developing operational strategy and guidelines aligned 
with the CDCs standards, stewarding intersectoral collaboration 
platforms, and ensuring strategic management of national health 
programs. The Disease Prevention and Control Bureau's standards 
development function shall be transferred to the Philippine Research 
Institute of Medicine: Provided, That the DOH Undersecretary for 
Operations and the DOH Regional Offices shall continue to perform their 
role in operational planning, coordination, and performance 
management.
(5) The Communications Office of the DOH shall be a shared service among 
DOH offices, including the FDA, CDC and Philippine Research Institute 
of Medicine, and shall perform, but not limited to, the following 
functions:
(i) 
Develop strategic communication plans, including, but not limited 
to organizational risk and crisis communication plans;
(ii) 
Manage and implement risk communication activities and 
initiatives, such as the development and issuance of information 
and education communication materials, events, stakeholder 
meetings, and other media engagement activities;
(iii) 
Manage and activate crisis communication protocol for health 
risks and hazards, and institutional reputational risks;
(iv) 
Develop and implement corresponding capacity-building activities 
in relation to organizational risk and crisis communications;
(v) 
Perform internal communication functions within the institution;
12


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
(Vi)
(vii)
(viii)
Develop and facilitate the approval of communication materials 
and policies as aligned with the approved communication plans; 
Manage different platforms of the institution for release of 
communication materials; and
Foster, maintain, and continuously build external partnership and 
communication networks with public and private health 
institutions.
(b)Transfer of Human Resource and Properties. The offices affected by the 
transfer of agencies shall also transfer human resource, applicable funds 
and appropriations, records, equipment, and property to the CDC, subject 
to a multi-year transition plan under Section 24 of this Act.
(1) As a result of the reorganization under this Act, the DOH shall evaluate 
the credentials, skills, and work experience of all employees in affected 
agencies, offices, or bureaus and shall conduct matching to positions 
within the new offices/bureaus created based on the set qualification 
standards. The DOH shall develop a technical working group to ensure 
that Republic Act No. 6656, or An Act to Protect the Security of Tenure 
of Civil Service Officers and Employees in the Implementation of 
Government Reorganization shall be properly observed towards the 
protection of the security of tenure of affected employees and shall 
institute mechanisms for retooling. To this end, there shall be no 
diminution of salaries and benefits of affected employees. Affected 
employees may opt for voluntary separation from service within six (6) 
months from the effectivity of this Act and shall be entitled to receive 
separation and early retirement benefits and other benefits under 
applicable laws and issuances within ninety (90) days from the date of 
effectivity of their separation; and
(2) Transfer of human resource, applicable funds and appropriations, 
records, equipment, and property to the CDC, among others, shall 
commence within two (2) years from effectivity of this Act to enable the 
smooth transfer of the same from the DOH.
13


1 
Sec. 10. Salary, Staffing Pattern and Qualifications. — The CDC staffing
2 
requirement shall be supported to ensure its role as the technical authority in the
3 
prevention and control of all diseases of public health importance. Subject to the
4 
review and approval of the Department of Budget and Management (DBM), the
5 
Secretary of Health shall determine the organizational structure and staffing pattern
6 
of the CDC, in accordance with existing Civil Service Commission laws, rules and
7 
regulations: Provided, That the existing law on salary scales of government employees
8 
shall not apply in determining the salary scale of scientific and highly technical staff.
9 
Members of advisory committees shall receive a per diem allowance for each
10 
meeting attended. The CDC shall include a summary of the amounts deemed
11 
necessary for the expenses of advisory committees in its budget recommendations:
12 
Provided, That all in-house technical and scientific staff, expert pools, and members
13 
of advisory committees shall be allowed to practice their profession and receive
14 
additional compensation from such engagements: Provided, further. That all employed
15 
staff and engaged in-house experts shall submit declaration of conflict-of-interest,
16 
non-disclosure agreement, and other pertinent documentary requirements as may be
17 
deemed necessary.
18 
All CDC personnel shall be authorized to undergo secondment to local and
19 
international academic and science-based organizations, local and international
20 
academic or technical training and capacity-building, or other similar knowledge
21 
exchange mechanisms to maintain the technical expertise necessary to implement the
22 
roles and responsibilities assigned to them: Provided, That the mechanisms for return
23 
of service are implemented, to be determined by the CDC and approved by the
24 
Secretary of Health.
25 
Sec. 11. Director General, Deputy Director Generals, and Directors. —
26 
(a) Appointment of the Director General. The Director General shall be
27 
appointed by the President, with the rank of Undersecretary, upon the
28 
recommendation of the Secretary of Health, based on technical expertise,
29 
academic background, and appropriate work experience.
30 
(b) Appointment of the Deputy Director Generals. The Director General shall be
31 
assisted by Deputy Director Generals, with the rank of Assistant Secretary.
32 
They shall oversee the functions of the Offices and Centers, and any
14


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
additional offices created in accordance with Section 7 of this Act. The 
Deputy Director Generals shall likewise be appointed by the President, upon 
the recommendation of the Secretary of Health, based on technical 
expertise, academic background, and appropriate experience.
(c) Appointment of Directors. The Director General shall be assisted by the 
following:
(1) Director for Health Economics Service with the rank of Director IV;
(2) Director for Policy and Planning with the rank of Director IV; and
(3) Director for Administration, Finance, and Legal Affairs with the rank 
of Director IV.
(d) Qualifications and Eligibilities
(1) The Director General shall be a public health professional, must be a 
licensed medical doctor, with at least 15 years of combined 
postgraduate experience in relevant fields of medicine, public health, 
research, and management;
(2) The Deputy Director General of each Center shall possess a 
postgraduate degree, preferably a doctorate, in fields related to 
medicine, public health or research, with management experience in 
such fields; and
(3) The Directors directly under the Office of the Director General shall 
possess third level service eligibility with educational background in 
relevant fields of medicine, public health, accounting, management, 
economics or any business course, and must have management 
experience in the aforesaid fields.
(e) Powers and Functions of the Director General
(1) Provide leadership, policy guidance, coordination, technical 
expertise, and services to promote the development and 
implementation of the CDCs national programs;
(2) Determine the occurrence of a public health emergency and with the 
concurrence of the Secretary of Health, certify to the President of the 
Philippines the occurrence of a public health emergency;
15


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
32
(3) Notify the WHO and other focal points of any public health 
emergency or incident in accordance to International Health 
Regulations guidelines, and lead in the coordination of public health 
response with said bodies and National Focal Points;
(4) Institute public health surveillance programs in accordance with 
Republic Act No. 11332, or the Mandatory Reporting of Notifiable 
Diseases and Health Events of Public Health Concern Act and as such, 
impose the following:
(i) 
Require all public and private hospitals, clinics, health facilities, 
laboratories, institutions, workplaces, schools, prisons, ports, 
airports, estabiishments, communities, other government 
agencies, and non-governmental organizations to accurately 
and immediately report notifiable disease and public health 
events to CDC;
(ii) 
Require all public and private hospitals, clinics, health facilities, 
and laboratories to submit health and health-related data, 
which shall include administrative, public health, medical, 
pharmaceutical, and financing data to CDC; and
(iii) 
Direct Disease Surveillance Officers, Epidemiology and 
Surveillance Units, CDC Laboratories, Philippine Health 
Laboratory System, pharmacies, and those employed by the 
LGUs involved in surveillance and response to report 
information required by the CDC at all times and as soon as 
practicable.
Failure of said establishments to report to the CDC shall 
constitute as a violation of Section 9 (d) and (e) of Republic Act No. 
11332, or the Mandatory Reporting of Notifiable Diseases and Health 
Events of Public Heaith Concern Act.
(5) Coordinate with the relevant agencies to furnish the CDC any sample 
of any substance or matter in the possession or control of that 
person, whether taken pursuant to this Act or otherwise, may be 
considered necessary or appropriate, or any information as may be
16


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
32
required by the CDC, within the period it requires for the purpose of 
any public health surveillance program, epidemiological investigation, 
or survey conducted pursuant to this Act.
For purposes of this Act, "epidemiological investigation" shall 
refer to an inquiry to the incidence, prevalence, extent, source, mode 
of transmission, causation of, and other information pertinent to a 
disease occurrence;
(6) Request the assistance of the Philippine National Police or the 
National Bureau of Investigation to locate any patients or persons 
suspected of contracting a communicable disease;
(7) Certify to the President of the Philippines, through the Secretary of 
Health, the termination of a public health emergency, which may 
serve as basis for the de-escalation and eventual termination of 
emergency response activities;
(8) Develop policies with provisions on penalties for local implementation 
and enforcement, in consultation with the Secretary of Health:
i) Provide recommendations on the corresponding rules and 
regulations, as well as penalties, for local implementation and 
enforcement that are necessary to control and prevent diseases 
within the country and to prevent the introduction, transmission, 
or spread of communicable diseases from other countries into the 
Philippines or from one domestic seaport/airport to another; and
ii) Provide public health preventive measures and intervention 
strategies such as health education, promotion and advisories, 
isolation, quarantine, inspections, fumigation, disinfection, 
disinfestation, vector control, pest extermination, and destruction 
of animals or articles found to be infected or contaminated as to 
be sources of infection to human beings in coordination with other 
concerned quarantine agencies such as veterinary quarantine, 
plant quarantine, and other measures as may be necessary.
(9) Develop and coordinate with the Secretary of Health the containment 
strategies for inland contagion or community transmission of public
17


1 
health threats. During public health emergencies, the DOH shall
2 
coordinate with the Bureau of Quarantine in controlling, directing,
3 
and managing all quarantine stations, grounds, and anchorages, and
4 
in designating their boundaries in accordance with Section 6 of
5 
Republic Act No. 9271, or the Quarantine Act of 2004;
6 
(10) Provide or obtain technical assistance to or from regional and local
7 
health departments, private agencies, and international and
8 
supranational agencies before, during, and after public emergencies;
9 
(11) Develop a shared risk communication plan in coordination with
10 
the DOH and the FDA;
11 
(12) Liaise with other government agencies, non-governmental
12 
organizations, international organizations, including the WHO,
13 
learning and academic institutions, and other pertinent groups or
14 
entities in the conduct of activities relating to disease prevention and
15 
control;
16 
(13) Coordinate with appropriate DOH Offices regarding administrative
17 
and program matters;
18 
(14) Appoint eligible persons in accordance with Civil Service Law,
19 
rules and regulations, and this Act;
20 
(15) Delegate the powers vested under this Act to the Deputy Director
21 
Generals; and
22 
(16) Perform such other functions as may be mandated by law, or as
23 
may be delegated by the Secretary of Health and/or the President.
24 
Sec. 12. Special Powers of the President - Upon the certification of the
25 
existence of a public health emergency, in accordance with Section 11 (5)(b) of this
26 
Act, may exercise the special powers, including mobilization of the governmental and
27 
nongovernmental agencies, including the private sector. The President shall respond
28 
to the threats and be authorized to do the following functions:
29 
(a) Develop and initiate the implementation of national policies to prevent and
30 
mitigate further transmission of diseases of public health importance;
31 
(b) Direct the DILG, for proper information dissemination to LGUs of all rules,
32 
regulations, and directives issued by the National Government pursuant to
18


1 
this Act: Provided, That all LCDs are authorized to develop localized policies
2 
and interventions provided these are aligned with the national policy, rules
3 
and regulations;
4 
(c) Direct the DOH to ensure adequate and equitable distribution of health
5 
workers during public health emergencies and the provision of social
6 
benefits and protection of health workers and their families and other
7 
household members against discrimination;
8 
(d) Ensure that concerned government agencies implement measures to
9 
protect the people from hoarding, profiteering, injurious speculations,
10 
manipulation of prices, monopolistic practices, other acts in restraint of
11 
trade, or other pernicious practices affecting the supply, distribution, and
12 
movement of food, clothing, hygiene and sanitation products, medicines
13 
and medical supplies and devices, machinery equipment and spare parts
14 
required in agriculture, industry, other essential services, and other articles
15 
of prime necessity, whether imported or locally produced or manufactured;
16 
(e) Ensure through concerned government agencies that the donations
17 
intended to address public health emergencies, the acceptance thereof, and
18 
distribution of donated health products and commodities are not
19 
unnecessarily delayed considering their shelf-life, and that health products
20 
and commodities for donation duly certified by the national regulatory
21 
authorities or their accredited third party from countries with established
22 
regulation shall be automatically cleared; and
23 
(f) Perform such other functions and activities, as deemed necessary.
24 
ARTICLE V
25 
RESPONSE ACTION
26 
Sec. 13. Response Cascade. — In case of public health emergencies due to
27 
biological, chemical, and toxic events:
28 
(a) The CDC, through the Philippine Research Institute of Medicine, shall
29 
prepare and disseminate to the public and private sector the relevant
30 
technical information and guidance;
19


1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
31
(b) The DOH, through the Public Health Strategy and Management Bureau, 
shall develop operational and intersectoral strategies guided by the 
strategies and standards developed by the CDC;
(c) The DOH, through its regional offices, shall work closely with CDC, 
through its regional CDCs to immediately respond to the public health 
emergency. When necessary, the DOH shall tap into the Disaster Risk 
Reduction and Management System to effectively respond to public 
health emergencies;
(d) The CDC, through the Philippine Research Institute of Medicine, shall 
activate the public health laboratory response network and continuously 
provide guidance for core laboratory programs in quality management, 
laboratory medicine and safety and security programs, laboratory 
information management and surveillance, research and development, 
and training;
(e) The CDC, through the Center for Epidemiology and Surveillance, shall 
certify the veracity of the official data to be used as basis for response 
and for public reporting, and provide standards and overall guidance to 
the Bureau of Quarantine for the institutionalization of disease 
surveillance at all points of entry and exit;
(f) The National Telecommunications Commission and any 
telecommunications entity as defined under Republic Act No. 7925, or 
the Public Telecommunications Policy Act of the Philippines, shall provide 
location information of patients or persons suspected of contracting a 
disease upon request of the CDC: Provided, That the CDC shall ensure 
confidentiality of such information;
(g) The Secretary of Health, in coordination with the CDC, may undertake 
the following functions in case of public health events:
1) Hire, transfer, and deploy health personnel;
2) Implement a whole-of-government and whole-of-society public 
health emergency preparedness and response, in cooperation with 
the DILG, LGUs, and the private sector;
20


1 
3) Strictly enforce and augment of border control and surveillance, in
2 
coordination with the Department of Foreign Affairs, Bureau of
3 
Quarantine, Bureau of Immigration, Philippine Ports Authority,
4 
Department of Agriculture, and Bureau of Customs;
5 
4) Commission research in coordination with DOST;
6 
5) Promote treatment, vaccination, or immunization against a
7 
contagious disease, compelling the isolation or quarantine of persons
8 
who are unable or unwilling, for reasons of health, religion, or
9 
conscience, to undergo immunization or treatment: Provided, That
10 
the guidelines for the exercise of such power shall be formulated with
11 
the Department of Justice;
12 
6) Decontaminate any facility or decontaminate or destroy any material
13 
when the CDC reasonably suspects that the same may endanger
14 
public health, subject to the payment of just compensation
15 
guaranteed under the Constitution;
16 
7) Issue and enforce measures for safe handling and disposal of human
17 
and animal remains; and
18 
8) Require any health or funeral facility authorized by law to perform
19 
such services as are reasonable and necessary to respond to a public
20 
health emergency.
21 
ARTICLE VI
22 
SPECIAL POWERS/AUTHORITY TO ENABLE RESPONSE
23 
Sec. 14. Authority for Other Professions to Administer, Dispense, and Provide
24 
Commodities for Pubiic Heaith Emergencies. — Notwithstanding any law to the
25 
contrary, the Secretary of Health, with the recommendation of the CDC, shall allow
26 
other health and allied medical professionals, such as pharmacists and midwives, who
27 
are duly trained by the DOH or its authorized representatives, to administer, dispense,
28 
and provide commodities considered as vital for public health emergencies with special
29 
authorization or regular certificate of registration from the FDA.
30 
Sec. 15. Issuance of Special Regulatory Authorizations. — The CDC shall
31 
recommend to the Secretary of Health the implementation of interventions under
32 
special regulatory authorization issued by the FDA, pursuant to Section 4 of Republic
21


1 
Act No. 3720, as amended by Republic Act No. 9711, or the FDA Act of2009. In
2 
consultation with the Heaith Technology Assessment Council (HTAC), the FDA shall be
3 
authorized to issue special authorizations for commodities during public health
4 
emergencies, provided that the following are complied with:
5 
a) The special regulatory authorization is based on the totality of available
6 
scientific evidence, including data from adequate and well-documented
7 
controlled trials, and it is reasonable to believe that the health product
8 
may be effective to prevent, diagnose, or treat the disease/s of concern;
9 
b) The potential benefits of the health product when used to diagnose,
10 
prevent, or treat disease/s of concern outweigh the known and potential
11 
risks, if any; and
12 
c) There is no adequate, approved, and available alternative to the health
13 
product for diagnosing, preventing, or treating disease/s of concern.
14 
In the event that the declared public health emergency is lifted, special
15 
authorizations issued by the FDA shall have provisional validity for a period of one (1)
16 
year from the date of lifting of the declaration for the sole purpose of exhausting
17 
remaining supplies.
18 
Sec. 16. Inter-agency Cooperation and Confidentiality. - For the purpose of
19 
expediting the review of evidence, product authorization or registration, and the
20 
appropriate release of recommendations and supporting policies, the DOH, FDA,
21 
FITAC, and other relevant government agencies shall, without need for notice or
22 
demand, immediately provide each other with any and all needed information:
23 
Provided, That proprietary submissions of data, which include non-disclosure
24 
agreements with manufacturers, traders, distributors, or other sources, shall also be
25 
subject of non-disclosure agreements with other concerned agencies.
26 
Sec. 17. Procurement of Commodities and Services for Public Health
27 
Emergencies by the DOH. — The CDC shall recommend to the Secretary of Flealth the
28 
procurement of essential commodities and services during public health emergencies.
29 
The DOFI and authorized parties, such as the LGUs and private entities, shall be
30 
allowed to procure commodities for public health emergencies that are recommended
31 
by any of the following:
22


1 
a) HTAC, pursuant to Section 34 of Republic Act No. 11223, or the Universal
2 
Health Care Act;
3 
b) WHO; or
4 
c) Similar emergency authorizations from reputable and stringent
5 
regulatory authorities of other countries,
6 
To this end, the President may authorize the DOH and other parties to enter
7 
into alternative modes of expedited procurement with United Nations Agencies,
8 
international organizations, or international financing institutions and their operational
9 
arms, such as, but not limited to, the WHO, United Nations Office for Project Services,
10 
United Nations Children's Fund, and other third parties, subject to the rules and
11 
policies set by the Department of Finance (DOF).
12 
Notwithstanding any law to the contrary, the DOH may disburse funds as
13 
advance payment if required by the manufacturer, trader, or distributor: Provided,
14 
That the authority to make advance payment shall be for the procurement of
15 
commodities for public health emergencies and to secure other goods and services
16 
necessary for their storage, transport, deployment, and administration: Provided
17 
further, That the distribution and administration of unauthorized commodities for
18 
public health emergencies shall be prohibited.
19 
Health Technology Assessment shall not be required for repurposing or stock
20 
realignment of commodities during public health emergencies that have already been
21 
procured by the DOH, LGUs, and private sector entities: Provided, That repurposing
22 
or stock realignment shall be in accordance with the indication of its use as approved
23 
by the FDA.
24 
Sec. 18. Authority to Direct the Operations of Private Estabiishments During
25 
Public Health Emergencies. — Consistent with Sec. 17, Article XII of the Constitution,
26 
when public interest so requires, the President, during public health emergencies, may
27 
direct the operations of any privately-owned hospitals and medical and health facilities,
28 
including passenger vessels, and other establishments, to perform functions and
29 
provide support services for public health emergency response, including housing
30 
health workers; serving as quarantine areas, quarantine centers, medical relief and
31 
aid distribution locations, or other temporary medical facilities; and ferrying health,
32 
emergency, and frontline personnel and other persons: Provided, That the
23


1 
management and operation of such establishments shall be retained by the owners:
2 
Provided, further, That reasonable compensation for any additional damage or costs
3 
incurred by the owner or the possessor of the subject property solely on account of
4 
complying with the directive shall be given to the person entitled to the possession of
5 
such private properties or businesses after the situation has stabilized or at the soonest
6 
time practicable: Provided, finaiiy. That if the foregoing establishments unjustifiably
7 
refuse or signify that they are no longer capable of operating their enterprises for the
8 
purpose stated herein, the President may take over their operations subject to the
9 
limits and safeguards enshrined in the Constitution.
10 
Sec. 19. Transition to Reguiar Authorization. — The FDA shall be authorized to
11 
develop specific guidelines on the transition of the regulatory authorization of
12 
commodities for public health emergencies from special use authorization to regular
13 
certificate of registration. This is in consideration of the time needed to process
14 
applications of health products for public health emergencies. The granting of a
15 
regular certificate of registration by the FDA to the first brand deemed suitable for
16 
such registration shall not immediately revoke all other special authorizations granted
17 
by the FDA to other brands, any law to the contrary notwithstanding: Provided, That
18 
once the DOH and the FDA had determined that the suppliers granted with regular
19 
certificate of registration have enough capacity to supply the country's projected
20 
needs, all other special authorizations issued shall be deemed revoked by this Act,
21 
without prejudice to their holders completing the process to obtain a regular certificate
22 
of registration: Provided, further. That any remaining stocks with a valid shelf-life but
23 
with a special authorization revoked pursuant to this provision shall either be donated
24 
to a country where its use is still authorized by its national regulatory authorities, or
25 
held in storage until it is registered or disposed of appropriately upon the termination
26 
of its shelf-life.
27 
Sec. 20. Immunity from Liabiiity. — Notwithstanding any law to the contrary,
28 
program implementors, public officials and employees, health care workers and non-
29 
health care workers, whether public or private who are authorized to carry out and
30 
are actually involved in public health emergency response shall be immune from suit
31 
and liability under Philippine laws with respect to all claims arising out of, related to,
32 
or resulting from the administration or use of covered countermeasures under the
24


1 
public health emergency response in the discharge of the above mentioned covered
2 
persons' official duties, except those arising from willful misconduct and gross
3 
negligence.
4 
The members of the FDA and the National Adverse Events Following
5 
Immunization Committee and its regional counterparts during the conduct of
6 
monitoring for probable adverse effects from the commodities for public health
7 
emergency shall similarly enjoy the privileges given under this section, waiving any
8 
liability unless the said members' actions are tantamount to gross negligence or willful
9 
misconduct.
10 
Sec. 21. Enabling Local Vaccine Manufacturing. — The DOFI and the CDC,
11 
together with the DOST and DTI and other entities concerned, shall develop initiatives
12 
for strengthening scientific and technological capabilities in responding to public health
13 
emergencies, including promoting vaccine self-reliance in the country. The Vaccine
14 
Self-Reliance National Action Plan shall serve as a road map for all stakeholders at all
15 
levels to guide the development of policies, strategies, and initiatives, such as but not
16 
limited to, incentivizing investment and maintenance of vaccine manufacturing
17 
infrastructure, both public and private.
18 
The National Government, through the DOF, shall ensure the provision of
19 
incentives, such as tax exemptions, tax breaks, or remittance, and other financing
20 
mechanisms, as applicable, to promote and enable the establishment of local vaccine
21 
manufacturing in the Philippines.
22 
ARTICLE VII
23 
MISCELLANEOUS PROVISIONS
24 
Sec. 22. Funding Mechanism for Scientific Projects and Activities. — The CDC
25 
shall establish a grant mechanism to allow direct transfer of funds to eligible public or
26 
private institutions to perform approved scientific projects and activities, including
27 
primary and secondary research and clinical practice guideline development, increased
28 
training and capacity-building opportunities for CDC personnel, in support of the
29 
priorities of the CDC.
30 
Sec. 23. Intergovernmental Collaborative Activities. — The CDC shall
31 
recommend to the Secretary of Foreign Affairs and the Secretary of Health multilateral
25


1 
and bilateral agreements which the country may adopt to strengthen its collaborative
2 
mechanisms with other countries.
3 
Sec. 24. Transitory Provision. — The CDC, in coordination with the DOH and
4 
LCDs, shall craft a multi-year plan to ensure the timely implementation of this Act. To
5 
this end, the multi-year plan shall include, but not limited to the following:
6 
(a) Phased expansion of the capacity of the CDC to cover other health
7 
conditions or threats in view of the needs of the Philippine health sector;
8 
(b)Transfer of human resource and properties
9 
(c) Require that every province and city-wide health system have full-time
10 
Disease Surveillance Officers, without prejudice to the need for Disease
11 
Surveillance Officers in municipalities, as may be deemed necessary;
12 
(d) Establishment of sub-national laboratories and regional public health
13 
laboratories;
14 
(e) Emergency funding and procurement of commodities and hiring during
15 
public health emergencies; and
16 
(f) Establishment of infrastructure and acquisition of parcels of land to
17 
house the national offices under the CDC.
18 
The DOH, upon coordination with the CDC, shall submit the funding
19 
requirements with corresponding annual targets for the implementation of the multi-
20 
year plan to the DBM and concerned agencies, for the determination of appropriate
21 
national budget allocation: Provided, That for local budget allocation, the LCDs shall
22 
also appropriate the necessary funds to ensure the proper implementation of this Act,
23 
in relation to their devolved functions under Republic Act No. 11223, or the Universal
24 
Health Care Act, and other existing laws.
25 
Sec. 25. Modernization Program. —The Director General shall, in consultation
26 
with the DOH, other concerned agencies of government and the private sector,
27 
develop a modernization program that will strengthen the human resource of the CDC,
28 
which is the key component of the country's disease prevention and control policy.
29 
The modernization program shall include, but not limited to, the acquisition and
30 
upgrading of appropriate technologies, laboratories, facilities, equipment, other
31 
needed resources, and the needed relocation and acquisition of additional land or
32 
location that would house the CDC.
26


1 
Within one hundred eighty (180) days from the effectivity of this Act, the
2 
Director General shall, with the recommendation of the DOH and DBM, submit the
3 
modernization program for the consideration and approval of Congress.
4 
The modernization program shall be immediately implemented and completed
5 
within five (5) years from the effectivity of this Act. Appropriations for the
6 
modernization program shall be charged against the annual General Appropriations
7 
Act.
8 
Sec. 26. Authority to Solicit, Negotiate, and Receive Donations, Grants, Gifts,
9 
Legacies, Endowments, and Contributions. — The CDC may solicit, negotiate with, and
10 
receive from any public or private domestic or foreign sources legacies, gifts,
11 
donations, grants, endowments, contributions or other transfers of ownership and/or
12 
possession of real or personal properties of all kinds for use in its operations, such as,
13 
but not limited to, upgrading of its facilities, and equipment outlay, development and
14 
expansion of human resource, and acquisition of the appropriate office spaces to
15 
improve the delivery of its services to the public.
16 
The Director General shall be authorized to retain, without need of a separate
17 
approval from any government agency, and subject only to existing accounting and
18 
auditing rules and regulations, all the legacies, gifts, donations, grants, endowments,
19 
contributions or other transfers of ownership and/or possession of real or personal
20 
properties of all kinds solicited, negotiated, and received by the CDC under this Act
21 
and other laws that it is mandated to administer based on the immediately prior year
22 
of operations: Provided, That the same, in addition to the annual budget of the CDC,
23 
shall be deposited and maintained in a separate account or fund, which may be used
24 
or disbursed directly by the Director General to fulfill the original purpose of the funds.
25 
Sec. 27. Tax Exemptions. — Donations, grants, gifts, endowments, legacies,
26 
and contributions used actually, directly and exclusively for the purpose of the CDC
27 
shall be exempt from donor's tax and the same shall be considered as allowable
28 
deduction from gross income for purposes of computing the taxable income of the
29 
donor, in accordance with the National Internal Revenue Code of 1997, as amended:
30 
Provided, That such other transfers of ownership and/or possession of all kinds of real
31 
or personal properties shall be exempt from all taxes.
27


1 
Sec. 28. Annual Report. — The CDC shall submit to Congress and the Office of
2 
the President an annual report containing the following:
3 
(a) Evaluation of the current and emerging threats to health in the country;
4 
(b) Progress in International Health Regulation commitments, as well as
5 
initiatives undertaken; and
6 
(c) Proposed legislative measures to address these threats.
7 
Sec. 29. Appropriations. — The amount necessary for the initial implementation
8 
of this Act shall be charged against the current year appropriations of the offices and
9 
agencies concerned. Thereafter, the funding requirements for the ensuing years shall
10 
be included in the annual General Appropriations Act.
11 
Sec. 30. Implementing Rules and Regulations. — The DOH shall promulgate
12 
the necessary implementing rules and regulations within ninety (90) working days
13 
from the effectivity of this Act.
14 
Sec. 31. Separability Clause. — If any provision of this Act is declared
15 
unconstitutional or otherwise invalid, the validity of the other provisions shall not be
16 
affected thereby.
17 
Sec. 32. Repealing Clause. — All laws, decrees, orders, rules and regulations,
18 
other issuances, or parts thereof, inconsistent with any provision of this Act, are
19 
hereby repealed or modified accordingly.
20 
Sec. 33. Effectivity. — This Act shall take effect fifteen (15) days after its
21 
complete publication in the Official Gazette or in two (2) newspapers of general
22 
circulation.
Approved,
28